Ian Milsom

Author PubWeight™ 91.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006 7.13
2 Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 2011 3.28
3 The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 2008 3.02
4 Advanced maternal age and adverse perinatal outcome. Obstet Gynecol 2004 3.01
5 Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States. Eur Urol 2011 2.81
6 The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int 2009 2.63
7 Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol 2008 2.41
8 Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur Urol 2009 2.33
9 National community prevalence of overactive bladder in the United States stratified by sex and age. Urology 2011 2.18
10 Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. BMJ 2007 1.97
11 Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial. Eur Urol 2012 1.95
12 Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. Contraception 2006 1.90
13 A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women. Eur Urol 2009 1.86
14 Influence of smoking, coffee, and tea consumption on bladder pain syndrome in female twins. Urology 2011 1.59
15 A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause 2002 1.57
16 Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int 2006 1.50
17 Design and validation of a new screening instrument for lower urinary tract dysfunction: the bladder control self-assessment questionnaire (B-SAQ). Eur Urol 2006 1.43
18 The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. BJU Int 2009 1.40
19 The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS. BJU Int 2011 1.38
20 Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women. Am J Obstet Gynecol 2003 1.37
21 Economic burden of urgency urinary incontinence in the United States: a systematic review. J Manag Care Pharm 2014 1.36
22 The economic impact of overactive bladder syndrome in six Western countries. BJU Int 2009 1.29
23 Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45-103 years. Eur Urol 2010 1.20
24 Hormonal contraception and venous thromboembolism. Acta Obstet Gynecol Scand 2012 1.20
25 Understanding the elements of overactive bladder: questions raised by the EPIC study. BJU Int 2008 1.12
26 Women's experience of coping with a positive Pap smear: A register-based study of women with two consecutive Pap smears reported as CIN 1. Acta Obstet Gynecol Scand 2003 1.12
27 Evidence for a secular trend in menopausal age: a population study of women in Gothenburg. Menopause 2003 1.12
28 A review of adherence to drug therapy in patients with overactive bladder. BJU Int 2008 1.06
29 Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstet Gynecol Scand 2002 1.06
30 The current and future burden and cost of overactive bladder in five European countries. Eur Urol 2006 1.06
31 Knowledge and attitudes about the Pap-smear screening program: a population-based study of women aged 20-59 years. Acta Obstet Gynecol Scand 2002 1.05
32 Dynamic progression of overactive bladder and urinary incontinence symptoms: a systematic review. Eur Urol 2010 1.04
33 Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer 2013 1.03
34 The prevalence of chronic constipation and faecal incontinence among men and women with symptoms of overactive bladder. BJU Int 2011 1.03
35 Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study. Cancer 2007 0.99
36 Overactive bladder syndrome in older people. BJU Int 2007 0.99
37 Overactive bladder: Is there a link to the metabolic syndrome in men? Neurourol Urodyn 2010 0.98
38 Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial. Int J Cancer 2013 0.98
39 Does HPV-status 6-12 months after treatment of high grade dysplasia in the uterine cervix predict long term recurrence? Eur J Cancer 2007 0.95
40 Overactive bladder is associated with erectile dysfunction and reduced sexual quality of life in men. J Sex Med 2008 0.95
41 Oestrogens and overactive bladder. Neurourol Urodyn 2013 0.94
42 UR-CHOICE: can we provide mothers-to-be with information about the risk of future pelvic floor dysfunction? Int Urogynecol J 2014 0.93
43 The performance of a new scoring system for colposcopy in detecting high-grade dysplasia in the uterine cervix. Acta Obstet Gynecol Scand 2005 0.93
44 The relationship between BMI and urinary incontinence subgroups: results from EpiLUTS. Neurourol Urodyn 2013 0.93
45 Can we prevent incontinence? ICI-RS 2011. Neurourol Urodyn 2012 0.91
46 Rationale for the study methods and design of the epidemiology of lower urinary tract symptoms (EpiLUTS) study. BJU Int 2009 0.90
47 Genetics and the lower urinary tract. Neurourol Urodyn 2010 0.90
48 Short- and long-term results of the tension-free vaginal tape procedure in the treatment of female urinary incontinence. Acta Obstet Gynecol Scand 2006 0.90
49 Risk of urinary incontinence symptoms in oral contraceptive users: a national cohort study from the Swedish Twin Register. Fertil Steril 2008 0.89
50 Examining lower urinary tract symptom constellations using cluster analysis. BJU Int 2008 0.88
51 Contraceptive use and pregnancy outcome in three generations of Swedish female teenagers from the same urban population. Contraception 2009 0.87
52 Expectant management of first-trimester miscarriage in clinical practice. Acta Obstet Gynecol Scand 2003 0.86
53 The effect of combined oral contraceptives and age on dysmenorrhoea: an epidemiological study. Hum Reprod 2012 0.86
54 Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL. Contraception 2007 0.85
55 The long-term influence of combined oral contraceptives on body weight. Hum Reprod 2011 0.85
56 Genetic influences are important for most but not all lower urinary tract symptoms: a population-based survey in a cohort of adult Swedish twins. Eur Urol 2011 0.85
57 Low persistence of anticholinergic drug use in Sweden. Eur J Clin Pharmacol 2011 0.85
58 The genetic and environmental contribution to the occurrence of bladder pain syndrome: an empirical approach in a nationwide population sample. Eur Urol 2010 0.83
59 The impact of OAB on sexual health in men and women: results from EpiLUTS. J Sex Med 2011 0.83
60 Lower urinary tract symptoms: lack of change in prevalence and help-seeking behaviour in two population-based surveys of women in 1991 and 2007. BJU Int 2009 0.83
61 Changes in attitudes, knowledge and hormone replacement therapy use: a comparative study in two random samples with 6-year interval. Acta Obstet Gynecol Scand 2005 0.81
62 Maternal fatalities, fetal and neonatal deaths related to motor vehicle crashes during pregnancy: a national population-based study. Acta Obstet Gynecol Scand 2008 0.81
63 The influence of the modifiable life-style factors body mass index and smoking on the outcome of mid-urethral sling procedures for female urinary incontinence. Int Urogynecol J 2015 0.80
64 Scientific evidence changes prescribing practice--a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003. BJOG 2006 0.79
65 Cost-effectiveness analysis of newer anticholinergic drugs for urinary incontinence vs oxybutynin and no treatment using data on persistence from the Swedish prescribed drug registry. BJU Int 2011 0.79
66 Faecal incontinence 20 years after one birth: a comparison between vaginal delivery and caesarean section. Int Urogynecol J 2014 0.79
67 The influence of intrauterine contraception on the prevalence and severity of dysmenorrhea: a longitudinal population study. Hum Reprod 2013 0.78
68 [Increasing number of Chlamydia infections--how can we reverse this trend?]. Lakartidningen 2002 0.78
69 Impact of recent studies on attitudes and use of hormone therapy among Scandinavian gynaecologists. Acta Obstet Gynecol Scand 2007 0.78
70 A longitudinal study of contraception and pregnancies in the same women followed for a quarter of a century. Hum Reprod 2010 0.78
71 Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS). Neurourol Urodyn 2012 0.78
72 Can we predict and prevent pelvic floor dysfunction? Int Urogynecol J 2015 0.77
73 Clustering of pelvic floor disorders 20 years after one vaginal or one cesarean birth. Int Urogynecol J 2015 0.77
74 Cervical cancer screening--"For better or worse...": women's experience of screening. Cancer Nurs 2006 0.76
75 Effects of estrogen plus progesterone on hemodynamic and vascular reactivity in hypertensive postmenopausal women. Blood Press 2010 0.76
76 Comparison of health care costs for open Burch colposuspension, laparoscopic colposuspension and tension-free vaginal tape in the treatment of female urinary incontinence. Neurourol Urodyn 2007 0.75
77 Editorial comment. Urology 2010 0.75
78 Maternal birth trauma: why should it matter to urogynaecologists? Curr Opin Obstet Gynecol 2016 0.75
79 [Increasing number of teenage pregnancies--multicultural approach in the preventive work is needed]. Lakartidningen 2003 0.75
80 The cervical cancer screening program from a midwife's perspective. Acta Obstet Gynecol Scand 2007 0.75
81 A three-armed randomized trial comparing open Burch colposuspension using sutures with laparoscopic colposuspension using sutures and laparoscopic colposuspension using mesh and staples in women with stress urinary incontinence. Acta Obstet Gynecol Scand 2005 0.75
82 A randomised trial comparing open Burch colposuspension using sutures with laparoscopic colposuspension using mesh and staples in women with stress urinary incontinence. BJOG 2004 0.75
83 Acute effects of transdermal 17beta-estradiol on hemostatic variables after 24-hour treatment. Clin Appl Thromb Hemost 2002 0.75
84 Influence of age and changes over time on erectile dysfunction: results from two large cross-sectional surveys 11 years apart. Scand J Urol 2012 0.75
85 Influence of chronic hormone replacement therapy on left ventricular mass and serum-ACE activity. Blood Press 2010 0.75
86 A focus on important reproductive health care issues - cancer, urinary incontinence and the consequences of pre-term birth. Acta Obstet Gynecol Scand 2010 0.75
87 The uterine cervix and the importance of cervical secretions. Acta Obstet Gynecol Scand 2009 0.75